Variant report
Variant | nsv520116 |
---|---|
Chromosome Location | chr6:153822736-153866043 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:153551820..153552804-chr6:153832962..153833839,3 | MCF-7 | breast: | |
2 | chr6:153858319..153861041-chr6:153861487..153863317,2 | K562 | blood: | |
3 | chr6:153803007..153804639-chr6:153864655..153867623,2 | K562 | blood: | |
4 | chr6:153323561..153325698-chr6:153833615..153836225,2 | K562 | blood: | |
5 | chr6:153633466..153634018-chr6:153833051..153833685,2 | MCF-7 | breast: | |
6 | chr6:153858319..153861041-chr6:153861487..153863317,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AL590867.1-2 | chr6:153861937-153862090 | XLOC_005508 |
2 | lnc-AL590867.1-2 | chr6:153860947-153861008 | XLOC_005508 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000112031 | chromatin interactions |
ENSG00000213121 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541877688 | chr6:153832987-153832988 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs553988669 | chr6:153833005-153833006 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs572375469 | chr6:153833021-153833022 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs200635911 | chr6:153833078-153833079 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs386707268 | chr6:153833079-153833080 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs79470249 | chr6:153833081-153833082 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs374047793 | chr6:153833082-153833083 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs374795459 | chr6:153833122-153833123 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs181348422 | chr6:153833131-153833132 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs544026626 | chr6:153833143-153833144 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs562217891 | chr6:153833156-153833157 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs551384284 | chr6:153833157-153833158 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs548235129 | chr6:153833191-153833192 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs185182240 | chr6:153833195-153833196 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs555212803 | chr6:153833206-153833207 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs527259980 | chr6:153833212-153833213 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs551921951 | chr6:153833219-153833220 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs570407344 | chr6:153833255-153833256 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs6926228 | chr6:153833256-153833257 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs150834882 | chr6:153833353-153833354 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs1626033 | chr6:153833398-153833399 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs549671383 | chr6:153833407-153833408 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs189788473 | chr6:153833409-153833410 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs114495636 | chr6:153833410-153833411 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs554217073 | chr6:153833443-153833444 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs143642839 | chr6:153833479-153833480 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs270272 | chr6:153833489-153833490 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs539811141 | chr6:153833514-153833515 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs1459254 | chr6:153833553-153833554 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs270271 | chr6:153833568-153833569 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs368675719 | chr6:153833641-153833642 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs76151284 | chr6:153833652-153833653 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs544088763 | chr6:153833653-153833654 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs182395288 | chr6:153833667-153833668 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs377291844 | chr6:153833685-153833686 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs372457434 | chr6:153833698-153833699 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs139233205 | chr6:153833704-153833705 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs573601460 | chr6:153833777-153833778 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs560179958 | chr6:153833789-153833790 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs375632185 | chr6:153833818-153833819 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs552149839 | chr6:153833862-153833863 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs563695411 | chr6:153833871-153833872 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs149589920 | chr6:153833891-153833892 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs549634628 | chr6:153833952-153833953 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs568039504 | chr6:153833963-153833964 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs573231424 | chr6:153833985-153833986 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs186424868 | chr6:153834056-153834057 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs535531852 | chr6:153834094-153834095 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs535622326 | chr6:153834213-153834214 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs547315294 | chr6:153834225-153834226 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:153833000-153833400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:153833000-153833400 | Enhancers | Adipose Nuclei | Adipose |
3 | chr6:153833000-153833600 | Enhancers | Dnd41 | blood |
4 | chr6:153842200-153842600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr6:153858200-153858400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr6:153858600-153859400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr6:153859400-153859600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:153859400-153861800 | Enhancers | Dnd41 | blood |
9 | chr6:153859600-153860000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr6:153859600-153860200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr6:153860400-153860600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr6:153860600-153861400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr6:153860600-153861600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |